| BCBS Florida Coverage Guidelines | Omacetaxine Mepesuccinate (Synribo®) (09-J1000-87) | 2019-02-15 |
| BCBS Florida Coverage Guidelines | Pirfenidone (Esbriet®) (09-J2000-24) | 2019-01-15 |
| BCBS Highmark Penn CPA/SEPA/WPA/NEPA | Daunorubicin and Cytarabine Liposomal (Vyxeos) | 2019-01-01 |
| BCBS Highmark Delaware | Mitochondrial DNA Deletion Syndromes | 2019-01-01 |
| BCBS Highmark Delaware | Familial Adenomatous Polyposis Testing | 2019-01-01 |
| BCBS Highmark Delaware | Mitochondrial Neurogastrointestinal Encephalopathy (MNGIE) | 2019-01-01 |
| BCBS Highmark Delaware | Daunorubicin and Cytarabine Liposomal (Vyxeos) | 2019-01-01 |
| BCBS Highmark West Virginia | PedPVD: Vascular Anomalies | 2019-01-01 |
| BCBS Highmark West Virginia | PEDPVD-2: Vasculitis | 2019-01-01 |
| BCBS Highmark West Virginia | PedPND: Neurofibromatosis | 2019-01-01 |